PTA-News: Vidac Pharma Holding PLC: Reaches Last Patient Last Visit in Phase 2b Study of VDA-1102 in Actinic Keratosis
Vidac Pharma Holding PLCby Sandra GamzonBusiness news for the stock market London (pta/15.09.2026/08:40) - Vidac Pharma Holdings Plc., a clinical-stage biopharmaceutical company developing first-in-class therapies targeting cancer cell metabolism, today announced that the last patient's last visit…
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.